• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.35 -0.22 (-1.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
November 09, 2021
Gainers Frequency Therapeutics (NASDAQ:FREQ) stock rose 10.94% to $7.51 during Tuesday's regular session. The current volume of 277.7K shares is 160.43% of Frequency... 
Via Benzinga
News headline image
58 Stocks Moving In Monday's Mid-Day Session ↗
November 09, 2021
Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH... 
Via Benzinga
News headline image
EXCLUSIVE: Benzinga Interviews Mind Cure CEO Kelsey Ramsden with Updates on Latest Press Release ↗
November 09, 2021
Image by: iStock The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored conte... 
Via Benzinga
News headline image
Compass Pathways' Psilocybin Therapy Shows Mixed Results From Depression Trial ↗
November 09, 2021
​​​​​Compass Pathways plc (NASDAQ: CMPS) has announced results from Phase 2b trial of COMP360 psilocybin therapy for treatment-resistant depression. The study has... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 09, 2021
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
News headline image
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval ↗
November 08, 2021
Detroit Decriminalizes Psychedelics 
Via Benzinga
News headline image
Compass Pathways 2.0: A New Rally In Psychedelic Stocks? ↗
November 04, 2021
Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? 
Via Talk Markets
Topics Initial Public Offering
NetworkNewsAudio – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers Hope on the Smoking-Cessation Horizon
November 04, 2021
Via Investor Brand Network
News headline image
This Psychedelics Unicorn's Stock Is Up 50% In One Month—Beating Bitcoin, Ethereum And Dogecoin ↗
November 04, 2021
Shares from psychedelics unicorn Compass Pathways (NASDAQ:CMPS... 
Via Benzinga
Artificial Intelligence Could Be About To Replace Your Doctor
November 02, 2021
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – November 2, 2021 – The US health and medical insurance industry is a $1.1-trillion maze that is impossible to navigate. And... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Increasing Prevalence of Depression & Mental Health Disorders Fueling Huge Growth in Psychedelic Drugs Market
November 04, 2021
Palm Beach, FL –November 4, 2021 – FinancialNewsMedia.com News Commentary – The pace of society’s change in attitude to the use of psychedelics has been amazing. It has gone from a “Born To Be Wild”,... 
Via FinancialNewsMedia
Topics Law Enforcement
News headline image
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent ↗
October 26, 2021
The Week In Psychedelics 
Via Benzinga
News headline image
Psychedelic Stocks Rebounded 9% Last Week; Small Pharma Was Up 148% ↗
October 24, 2021
The Psychedelic Compounds-Based Drug Stocks Index was up +8.9% last week albeit still down -18.5% YTD. 
Via Talk Markets
Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and More
November 01, 2021
Via Investor Brand Network
News headline image
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up? ↗
October 23, 2021
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last. 
Via Talk Markets
News headline image
Down 25% in 2021, Is Compass Pathways Undervalued? ↗
October 22, 2021
It depends on how optimistic you are about its lead program. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021 ↗
October 29, 2021
Upgrades For Preferred Bank (NASDAQ: 
Via Benzinga
News headline image
Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race ↗
October 20, 2021
Small Pharma Inc. (OTCQB:DMTTF) (TSXV: 
Via Benzinga
News headline image
Psychedelic Unicorn Compass Pathways Receives New Patent Approval ↗
October 20, 2021
Compass Pathways (NASDAQ:CMPS), a unicorn company in the psychedeli... 
Via Benzinga
Topics Intellectual Property
North America Continues Leading The Way In Psychedelic Wellness
October 26, 2021
Palm Beach, FL –October 26, 2021 – FinancialNewsMedia.com News Commentary – The global psychedelic drugs market remains at an early stage in its life cycle, with most companies currently developing... 
Via FinancialNewsMedia
News headline image
This Company Just Extended its Reach into the United Kingdom by Opening its First Ketamine Therapy Clinic ↗
October 18, 2021
Photo by cottonbro from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner... 
Via Benzinga
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector
October 18, 2021
FN Media Group Presents Oilprice.com Market Commentary London – October 18, 2021 – A massive disruption now appears imminent in one of the world’s largest – and most important – industries. In much the... 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗
October 18, 2021
The Week In Psychedelics 
Via Benzinga
News headline image
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021 ↗
October 15, 2021
Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month. 
Via Talk Markets
News headline image
Psychedelic Stocks: Financial Strength, Growth Potential, Compelling Valuations ↗
October 12, 2021
Blue-chip stocks: grossly inflated valuations and loaded with debt. Psychedelic stocks: lean valuations and loaded with cash. A very attractive option in uncertain markets. 
Via Talk Markets
News headline image
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
News headline image
Why Compass Pathways Stock Dropped 12% in September ↗
October 05, 2021
Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy. 
Via The Motley Fool
U.S. Is Dominating Psychedelic Drugs Market Due To Growing Acceptance For Treating Depression & Rise In Product Approvals
October 12, 2021
Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – After being relegated to the margins of sincere scientific examination for about the last several decades, growing... 
Via FinancialNewsMedia
Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028
October 11, 2021
Palm Beach, FL –October 11, 2021 – FinancialNewsMedia.com News Commentary – There is a high demand for more advanced products for the treatment and maintenance of severe mental disorders. Thus,... 
Via FinancialNewsMedia
Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market
October 05, 2021
Palm Beach, FL – October 5, 2021 – FinancialNewsMedia.com News Commentary – The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely to... 
Via FinancialNewsMedia
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap